Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000492251 | SCV000580905 | pathogenic | Hereditary cancer-predisposing syndrome | 2012-11-30 | criteria provided, single submitter | clinical testing | This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Invitae | RCV001856951 | SCV002208639 | pathogenic | Peutz-Jeghers syndrome | 2021-04-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with Peutz-Jeghers syndrome (PMID: 14623934, 17924967, 22543132). ClinVar contains an entry for this variant (Variation ID: 428761). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln123*) in the STK11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in STK11 are known to be pathogenic (PMID: 15188174, 16287113). |
Myriad Genetics, |
RCV001856951 | SCV004933155 | pathogenic | Peutz-Jeghers syndrome | 2024-02-12 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |